Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes.
Saroj HattakitpanitchakulSirorat KobbuakleeKitsada WudhikarnChantana PolprasertPublished in: Asian Pacific journal of cancer prevention : APJCP (2021)
We conclude that a low serum EPO level is a predictive factor for responsiveness to ESAs in Asian patients with low-risk MDS.
Keyphrases